Skip to main content
Back to companies
Founded 202146+ employeesPrivate
$32.2M raisedSeries A· last: series a (Oct 2025)· 7 rounds

We are facing a global crisis where bacterial infections are becoming increasingly deadly due to antibiotic resistance. The health and economic consequences are staggering, with bacterial disease predicted to be the #1 cause of death by 2050. Alternatives are urgently needed, but nature already has its solution: phages, the natural predators of bacteria. At Phagos, we are bringing back phage technology by combining advances in microbiology with cutting-edge artificial intelligence. Our patented technology makes large-scale, customized phage-based veterinary medicines possible for the first time. And soon we'll universalize the technology for human health too. Our mission is to end bacterial disease.

Founders

Skip jobs list

Open Positions at phagos (0 Jobs)

No open positions at the moment.
Try adjusting your filters or browse all jobs
Browse All Jobs